NasdaqCM - Delayed Quote • USD
Sensus Healthcare, Inc. (SRTS)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 6:55 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | -0.05 | -0.01 | 0.04 | 0.2 |
| Low Estimate | -0.07 | -0.03 | 0.01 | 0.2 |
| High Estimate | -0.04 | 0 | 0.08 | 0.2 |
| Year Ago EPS | -0.12 | -0.02 | 0.03 | 0.04 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 1 |
| Avg. Estimate | 4.12M | 5.69M | 26.3M | 32.26M |
| Low Estimate | 3.91M | 5.3M | 25.81M | 32.26M |
| High Estimate | 4.32M | 6.09M | 26.79M | 32.26M |
| Year Ago Sales | 10.13M | 4.53M | 24.41M | 26.3M |
| Sales Growth (year/est) | -59.30% | 25.70% | 7.80% | 22.70% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 0.13 | -0.08 | -0.02 | 0.12 |
| EPS Actual | -0.12 | -0.02 | -0.09 | 0.26 |
| Difference | -0.25 | 0.06 | -0.07 | 0.14 |
| Surprise % | -192.30% | 75.00% | -350.00% | 116.70% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.05 | -0.01 | 0.04 | 0.2 |
| 7 Days Ago | -0.05 | -0.01 | 0.04 | 0.2 |
| 30 Days Ago | -0.03 | 0 | 0.11 | 0.18 |
| 60 Days Ago | -0.03 | 0 | 0.11 | 0.18 |
| 90 Days Ago | -0.03 | 0.01 | 0.02 | 0.12 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | SRTS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 58.30% | -- | -- | 1.60% |
| Next Qtr. | 50.00% | -- | -- | 10.50% |
| Current Year | 33.30% | -- | -- | 5.20% |
| Next Year | 400.00% | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.22% |
| Past 5 Years (per annum) | 100.07% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/13/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/7/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 5/4/2023 |
| Maintains | Alliance Global Partners: Buy | 5/4/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 2/10/2023 |
| Maintains | Alliance Global Partners: Buy | 2/10/2023 |
Related Tickers
BVS Bioventus Inc.
4.4800
-1.54%
SIBN SI-BONE, Inc.
15.42
+0.78%
SSKN STRATA Skin Sciences, Inc.
0.5450
+7.92%
SRDX Surmodics, Inc.
26.49
+0.38%
TCMD Tactile Systems Technology, Inc.
14.40
+1.84%
TELA TELA Bio, Inc.
4.7500
-7.77%
VERO Venus Concept Inc.
0.8150
+1.34%
APYX Apyx Medical Corporation
1.3200
-4.35%
OFIX Orthofix Medical Inc.
13.10
+0.61%
RBOT Vicarious Surgical Inc.
0.2880
+3.23%